Status:
RECRUITING
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Lead Sponsor:
Freenome Holdings Inc.
Conditions:
Lung Cancer Diagnosis
Eligibility:
All Genders
50+ years
Brief Summary
The PROACT LUNG study is a prospective multi-center observational study to validate a blood-based test for the early detection of lung cancer by collecting blood samples from high-risk participants wh...
Detailed Description
This is a prospective, multi-center, observational study to evaluate the performance of the Freenome Multiomics Blood Test in screening eligible participants for lung cancer. Enrollment will be open ...
Eligibility Criteria
Inclusion
- Age 50 years or older within 30 days of enrollment
- Current or former smokers with a cumulative smoking history of ≥ 20 pack-year
- Able to comprehend and willing to sign and date the informed consent and HIPAA authorization documents
Exclusion
- Any active therapy for cancer, including but not limited to surgery, chemotherapy, biologic therapy, immunotherapy, and/or radiation therapy at the time of enrollment
- History of any malignancy within prior 5 years of enrollment (except for non- melanoma skin cancer)
- History of organ, tissue, and bone marrow transplantation
- Screened for lung cancer or having chest CT scan 12 months before enrollment
- Having signs and symptoms of lung cancer such as hemoptysis, superior vena cava syndrome, Cushing syndrome, and Pancoast syndrome
- Received a blood transfusion in the 30 days preceding enrollment
- Known to be pregnant
- Participated or currently participating in another Freenome-sponsored clinical study
- Participated or currently participating in a clinical research study in which an experimental medication has been administered during the 60 days preceding enrollment
- Any condition that in the opinion of the Investigator should not be enrolled in the study
Key Trial Info
Start Date :
November 28 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 15 2027
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT06122077
Start Date
November 28 2023
End Date
June 15 2027
Last Update
August 5 2025
Active Locations (36)
Enter a location and click search to find clinical trials sorted by distance.
1
Science 37
Los Angeles, California, United States, 90230
2
Stamford Hospital
Stamford, Connecticut, United States, 06902
3
Hillcrest Medical Research
DeLand, Florida, United States, 32720
4
Universal Axon Clinical Research
Doral, Florida, United States, 33166